@article{article, title  = {{Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (The FREEDOM-C2 Study): A randomized controlled trial}},

 url = {{}},

 year = {{2013}},

 month = {{9}},

 author = {{Tapson VF and Jing ZC and Xu KF and Pan L and Feldman J and Kiely DG and Kotlyar E and McSwain CS and Laliberte K and Arneson C and Rubin LJ}},

 doi = {{10.1378/chest.12-2875}},

 volume = {{144}},

 journal = {{Chest}},

 issue = {{3}},

 pages = {{952-958}},

 note = {{Accessed on 2024/12/22}}}